Skip to main content

Table 2 Serum lipid profile and glucose levels of study population by HAART status at Burayu Health Center, Addis Ababa, Ethiopia, 2012

From: Antiretroviral treatment associated hyperglycemia and dyslipidemia among HIV infected patients at Burayu Health Center, Addis Ababa, Ethiopia: a cross-sectional comparative study

Parameters HAART initiated (n=126) Non-HAART (n=126)
N (%) N (%)
Glucose Mean ± SD 97.1 ± 15.7 92.2 ± 16.9*
≤110 mg/dl 116(92.1) 119(94.4)
>110 mg/dl 10(7.9) 7(5.6)
Triglycerides Mean ± SD 162.2 ± 92.7 131.5 ± 55.3**
<150 mg/dl 67(53.2) 87(69)
≥150 mg/dl 59(46.8) 39(31)*
Total cholesterol Mean ± SD 194.3 ± 45.2 147.2 ± 37.7***
<200 mg/dl 73(57.9) 112(88.9)
≥200 mg/dl 53(42.1) 14(11.1)***
HDL-cholesterol Mean ± SD 40.9 ± 12.9 32.6 ± 11.3***
<40 mg/dl 64(50.8) 92(73)***
≥40 mg/dl 62(49.2) 34(27)
LDL-cholesterol Mean ± SD 107.2 ± 35 81.4 ± 29.3***
<130 mg/dl 97(77) 117(92.9)
≥130 mg/dl 29(23) 9(7.1)***
  1. HAART, highly active antiretroviral therapy; HDL, high-density lipoprotein; LDL, low- density lipoprotein; SD, standard deviation; *p-value =0.01; **p-value =0.002; *** p-value <0.0001.